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Intake of Fermented Dairy Products Induces a Less
Pro-Inflammatory Postprandial Peripheral Blood
Mononuclear Cell Gene Expression Response than
Non-Fermented Dairy Products: A Randomized Controlled
Cross-Over Trial
Amanda Rundblad,* Kirsten B. Holven, Linn K. L. Øyri, Patrik Hansson, Ingvild H. Ivan,
Gyrd O. Gjevestad, Magne Thoresen, and Stine M. Ulven
Scope: It is aimed to investigate how intake of high-fat meals composed of
different dairy products with a similar fat content affects postprandial
peripheral blood mononuclear cell (PBMC) expression of inflammation-related
genes, as well as circulating inflammatory markers and metabolites.
Methods and results: Healthy subjects (n = 47) consume four different
high-fat meals composed of either butter, cheese, whipped cream, or sour
cream in a randomized controlled cross-over study. Fasting and postprandial
PBMC gene expression, plasma metabolites, and circulating inflammatory
markers are measured. Using a linear mixed model, it is found that expression
of genes related to lymphocyte activation, cytokine signaling, chemokine
signaling, and cell adhesion is differentially altered between the four meals. In
general, intake of the fermented products cheese and sour cream reduces,
while intake of the non-fermented products butter and whipped cream
increases, expression of these genes. Plasma amino acid concentrations
increase after intake of cheese compared to the other meals, and the amino
acid changes correlate with several of the differentially altered genes.
Conclusion: Intake of fermented dairy products, especially cheese, induces a
less inflammatory postprandial PBMC gene expression response than
non-fermented dairy products. These findings may partly explain inconsistent
findings in studies on health effects of dairy products.
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1. Introduction
Cardiovascular disease (CVD) is themain
cause of death worldwide, and atheroscle-
rosis is the underlying cause of most
CVDs.[1] The development of atheroscle-
rosis is characterized by accumulation of
cholesterol and other lipids in the inti-
mal space of the arteries, and a low-grade
inflammatory response.[2] Intake of satu-
rated fatty acids (SFA), especially C12:0-
C16:0, raises LDL-C in serum and may
trigger an inflammatory response, partly
by promoting LPS translocation to the
bloodstream that activates toll-like recep-
tor (TLR) 4.[3]
Dairy fat consists of about 65% SFA.
However, the effect of different dairy
products on LDL-C seems to vary, with
butter inducing a larger increase in LDL-
C than cheese.[4–7] Additionally, we pre-
viously showed that intake of different
dairy products with the same amount
of fat and fatty acid composition altered
the postprandial triglyceride (TG) profile
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differentially.[8] Controversies exist regarding health effects of
dairy intake.[9,10] However, high-fat and non-fermented dairymay
be associated with increased all-cause mortality and coronary
heart disease risk, while low-fat and fermented dairy show the
opposite effect.[11–14]
Different dairy products differ in food matrix and fermenta-
tion. In addition, they contain different amounts of nutrients
such as fat, protein, and calcium, with cheese having a par-
ticularly high protein and calcium content. In turn, this may
influence fat absorption, gut microbiota, as well as gene expres-
sion and blood metabolomics, which may affect different dairy
products’ effects on lipid metabolism and inflammation.[15,16] A
systematic review of randomized controlled trials concluded that
dairy intake was anti-inflammatory; however, the majority of the
studies investigated the effect of low-fat dairy.[17] In addition, in-
take of fermented dairy products seems to have a more beneficial
effect on circulating inflammatory markers than non-fermented
dairy products,[17] although conflicting results exist.[18] To our
knowledge, the effect of different high-fat dairy products on
inflammation-related gene expression is less studied.
Peripheral blood mononuclear cells (PBMCs) consist of lym-
phocytes, natural killer cells, and monocytes and are cells of
both the innate and adaptive immune system being important
in the inflammatory process of atherosclerosis.[2,19] PBMCs are
exposed to nutrients, metabolites, and peripheral tissues and are
easily isolated from a blood sample. In addition, PBMCs reflect
white adipose tissue postprandial inflammation-related gene ex-
pression, and liver fasting and cholesterol metabolism related
gene expression.[20–22] Thus, PBMCs may be used as a surro-
gate tissue to study intervention effects on lipid metabolism and
inflammation-related gene expression.
The aim of this study was to investigate how intake of four
high-fat meals composed of different dairy products affects post-
prandial inflammation and lipid metabolism related PBMC gene
expression and circulating inflammatory markers and metabo-
lites. We hypothesized that the fermented dairy products would
alter PBMC gene expression in a less pro-inflammatory manner
than the non-fermented dairy products as previous studies have
indicated a favorable effect of fermented dairy products.
2. Experimental Section
2.1. Subjects and Study Design
Healthy males and females aged 18–70 years were recruited
through social media, local newspapers, and posters at univer-
sities and hospitals in the Oslo area, Norway, between June 2016
and January 2017. Inclusion criteria were BMI > 18.5 kg m−2,
a stable weight (±5%) the past three months, and willingness
to eat the test meals. Exclusion criteria included elevated fast-
ing blood glucose (≥7 mmol L−1), C-reactive protein (CRP, >
10 mg L−1), total cholesterol (>6.1 mmol L−1 aged 18–29 years,
>6.9 mmol L−1 aged 30–49 years, and >7.8 mmol L−1 aged ≥50
years), or blood pressure (>160/100 mmHg), and severe chronic
disease, CVD, or cancer the past six months. Further exclusion
criteria included pregnant or lactating females, allergy or intol-
erance against gluten, lactose or milk protein, smoking, use of
lipid-lowering or anti-inflammatory medications, and unwilling-
ness to stop use of omega-3 supplements four weeks prior to and
Table 1. Nutritional composition of the study meals.




Energy [kJ] 2614 2981 2712 2726
Energy [kcal] 629 715 652 655
Carbohydrate [g] 45.3 45.1 48.4 48.6
Carbohydrate
[E%]
30.5 26.6 31.3 31.3
Protein [g] 8.8 30 10.9 11.2
Protein [E%] 5.7 17.2 6.9 7
Fat [g] 44.8 45.1 45.1 45.2
Fat [E%] 63.7 56.2 61.8 61.6
Calcium [mg] 9 678 85 94
E%, percent of energy; kcal, kilocalorie; kJ, kilo Joule.
during the study. Subjects willing to participate were contacted by
telephone and eligible subjects were invited to a screening visit at
the Center of Clinical Nutrition, Department of Nutrition at the
University of Oslo, Norway.
In this randomized cross-over study, subjects were served four
high-fat meals with four different dairy products containing the
same amount of fat, as previously described in detail.[8] Each
meal contained 45 g fat that corresponded to about 60 energy%
(E%), an amount of fat that would induce a postprandial TG
response,[23] as TG was the primary end point in this study. Fur-
thermore, a meal containing 50 g of butter is sufficient to trig-
ger an inflammatory response,[24] and was considered an edi-
ble amount for the participants. In short, each meal consisted
of three slices of toasted white bread (84 g), raspberry jam (20 g),
and either butter (52 g), cheese (113 g), whipped cream (113 g), or
sour cream (113 g). The nutritional composition of the meals is
shown in Table 1 and the fatty acid composition of the meals was
identical.[8] The subjects were not blinded, however, the meals
looked similar and the subjects were blinded to the allocatedmeal
order. Participants were randomized by the principal investiga-
tor to one of four fixed meal orders using block randomization in
Microsoft Excel’s random generator; 1: butter, cheese, whipped
cream, and sour cream, 2: cheese, whipped cream, sour cream,
and butter, 3: whipped cream, sour cream, butter, and cheese,
and 4: sour cream, butter, cheese, and whipped cream. Between
each meal, there was a washout period of three to five weeks for
premenopausal females not using contraceptives and minimum
two weeks for other participants. Subjects were instructed not to
change their habitual diet and physical activity level during the
study. Before each visit, subjects were instructed to fast for 12 h,
avoid strenuous physical activity and alcohol for 24 h, and to not
eat any fatty food after 6 pm the night before. At each test day,
a fasting blood sample was collected before each participant got
20min to eat the testmeal together with water. Amaximumof 1 L
water was allowed during each visit. Postprandial blood samples
were drawn 4 and 6 h after eating the meal.
This study was approved by the Regional Committees for
Medical and Health Research Ethics (2016/418/REK sør-øst
B) and conducted according to the principles laid down in
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the Declaration of Helsinki. All subjects gave their written
informed consent to participate. The study was registered at
www.clinicaltrials.gov (NCT02836106).
2.2. Blood Sampling and Biochemical Routine Measures
Whole blood was collected in EDTA tubes that were kept at room
temperature for maximum 48 h until white blood cell count
was performed at a routine laboratory (Fürst Medical Labora-
tory, Oslo, Norway). Plasma was collected in EDTA tubes (Becton
DickensonVacutainer Systems) that were kept on ice for<15min
before centrifugation (2000 × g, 15 min, 4 °C). Serum was col-
lected in silica gel tubes (Becton Dickenson Vacutainer Systems)
that were kept at room temperature for 30–60 min to allow for
complete coagulation before centrifugation (1500 × g, 15 min)
and storage at−80 °C. Standard biochemicalmeasures, including
total cholesterol, LDL-C, HDL-C, apolipoprotein A1 and B, glu-
cose, insulin, and high-sensitivity CRP (hsCRP) were measured
in fasting serum samples drawn at the first visit at an accredited
medical laboratory (Fürst Medical Laboratory, Oslo, Norway).
2.3. Isolation of Peripheral Blood Mononuclear Cells and RNA
PBMCs from blood samples drawn fasting and 4 h postprandially
were isolated with BD Vacutainer Cell Preparation tubes (Bec-
ton, Dickinson San Jose, CA, USA) which is a well-documented
PBMC isolation method with more than 90% purity. PBMCs
were isolated according to the manufacturer’s instructions and
were stored at −80 °C until RNA isolation. Total RNA was iso-
lated using the RNeasy kit with QIAshredder homogenization of
the cell lysates and DNase treatment using the automated proto-
col for the QIAcube according to the manufacturer’s instructions
(Qiagen, Valensia, CA, USA). The quantity and quality of the
isolated RNA were analyzed with the NanoDrop ND-1000 Spec-
trophotometer (Thermo Fisher Scientific, Gothenburg, Sweden)
and the Agilent RNA 6000 Nano kit using Agilent 2100 Bioana-
lyzer (Agilent Technologies, Santa Clara, CA, USA).
2.4. Gene Expression Analyses
RNA expression analysis was performed using the NanoString
nCounter system and the nCounter XT Human Immunology
V2 Panel (Nanostring Technologies). This immunology panel
contains code-sets that cover about 600 immune-relatedmRNAs,
15 reference genes, as well as positive and negative controls. All
gene name abbreviations are listed in Supporting Information.
In addition, the panel was customized by adding 30 additional
code-sets covering lipid metabolism related mRNAs (Table S1,
Supporting Information). The procedure was performed accord-
ing to the manufacturer’s instructions for nCounter Panel-Plus
with an RNA input of 75 ng per sample.
Samples with an imaging quality control > 75%, binding den-
sity between 0.1 and 1.8, positive control linearity > 0.95, and
a lowest positive control (0.5 fm) count higher than 2 SD above
the negative controls were included. Samples were normalized to
remove both technical and biological variation. The background
threshold was set to be the geometric mean of the negative con-
trols. Each sample was normalized to the mean of its positive
controls relative to the geometric mean of positive controls in
all samples. Finally, all samples were normalized to the 15 ref-
erence genes included in the panel (ABCF1, ALAS1, EEF1G,
G6PD, GAPDH, GUSB, HPRT1, OAZ1, POLR1B, POLR2A,
PPIA, SDHA, TBP, TUBB, and RPL19). The quality control and
the technical and biological normalization was performed in
the nSolver analysis software version 4.0 (NanoString Technolo-
gies). The stability of the 15 reference genes was assessed using
NormFinder.[25]
2.5. ELISA
Circulating inflammatory markers in serum samples drawn fast-
ing and 6 h postprandially weremeasured using ELISA. The con-
centration of circulating inflammatorymarkers was analyzed at 6
h, rather than 4 h, to be able to capture changes that could occur
as a result of gene expression changes. Concentrations of vas-
cular cell adhesion molecule-1 (VCAM-1) and intracellular adhe-
sion molecule-1 (ICAM-1) were measured with DuoSet ELISA
(R&D Systems, Minneapolis, MN, USA), while E-selectin, IL-6,
tumor necrosis factor alpha (TNF-𝛼), and TNF receptor 1 and 2
(TNFR1 and TNFR2) were measured with Quantikine kits (R&D
Systems). All assays were performed according to the manufac-
turer’s instructions.
2.6. Nuclear Magnetic Resonance Spectroscopy Analysis of
Plasma Metabolites
The EDTA plasma concentration of metabolic biomarkers at
0 and 4 h postprandially was quantified with a commercial
high-throughput 1H nuclear magnetic resonance (NMR) spec-
troscopy platform (Nightingale Health, www.nightingalehealth.
com). This platform quantifies the concentration of glycolysis-
related metabolites (glucose, lactate, and citrate), ketone bodies
(acetate, acetoacetate, and 3-hydroxybutyrate), amino acids (ala-
nine, glutamine, histidine, isoleucine, leucine, valine, phenylala-
nine, and tyrosine), creatinine and glycoprotein acetyls, as well
as the signal area for albumin. Details of the NMRmetabolomics
platform have previously been published.[26]
2.7. Statistical Analyses
Sample size was based on the expected response of the pri-
mary endpoint, TG, from previous intervention studies with
high-fat meals, and a post hoc power calculation has previously
been reported.[8] All statistical analyses were performed in R ver-
sion 3.5.1.[27] normalized counts of the 609 genes were log2-
transformed and the change from fasting to 4 h postprandially
(log-ratio) was calculated. The change in serum concentrations of
inflammatory markers from fasting to 6 h postprandially and the
change in plasma concentrations of metabolites analyzed with
NMR spectroscopy from fasting to 4 h postprandially were calcu-
lated directly from non-transformed concentrations.
The difference in gene expression, inflammatory marker,
and metabolite changes between the four meals were ana-
lyzed with a linear mixed model (lmer function) with meal,
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visit, sex, age, and BMI as fixed effects and subject ID as a
random effect using the lme4 package.[28] The genes with
a significant (p < 0.05) overall meal effect were manually
grouped by function based on information provided at NCBI
(https://www.ncbi.nlm.nih.gov/pubmed/), GeneCards (https:
//www.genecards.org), Uniprot (https://www.uniprot.org) as
well as gene annotations provided with the NanoString Human
Immunology Panel (https://www.nanostring.com/products/
gene-expression-panels/ncounter-immunology-panels). Genes,
inflammatory markers, and metabolites with a significant meal
effect were further analyzed for pairwise comparisons using
emmeans::lsmeans.[29] p-values from the six pairwise compar-
isons within a variable were adjusted using the Tukey method.
Between meal comparisons were considered significant with an
adjusted p-value < 0.05. The correlations between significant
gene expression changes and changes in metabolite concentra-
tions were analyzed with Spearman’s correlation using the rcorr
function.
Gene expression changes within ameal were analyzed by com-
paring log2-transformed counts fasting and 4 h postprandially,
while changes in inflammatory markers within a meal were ana-
lyzed by comparing fasting and 6 h postprandial concentrations,
using a paired t-test. Within-meal comparisons were considered
significant with an FDR q-value < 0.1.
The difference between themeals in change of lymphocyte and
monocyte composition relative to the total white blood cell pool
from fasting to 4 h was analyzed with mixed models with subject
ID as random effect.
Analyses of changes in PBMC mRNA expression of inflam-
mation and lipid metabolism related genes, changes in circu-
lating inflammatory markers, and changes in blood metabolites
were predeclared secondary outcomes (www.clinicaltrials.gov,
NCT02836106), while the analysis of metabolite-gene expression
correlations were exploratory.
3. Results
3.1. Characteristics of the Study Population
In total 47 participants consumed at least one of the four test
meals and were included in this study. A flow-chart showing par-
ticipant losses and exclusions from assessment of eligibility to
completion of the study has previously been published.[8] Partic-
ipants were 70% female, on average (SD) 35 (12) years and had
a BMI of 24.1 (3.9) kg m−2. Fasting TG, total cholesterol, LDL-
C, HDL-C, apolipoprotein A1 and B, glucose, insulin, hsCRP,
and blood pressure were within the normal ranges (Table 2).
The BMI of the participants did not change during the study, as
previously reported.[8] The habitual dietary intake of macronutri-
ents among the participants was 35.0 E% total fat, 12.6 E% SFA,
13.1 E% MUFA, 6.1 E% PUFA, 17.7 E% protein, and 41.5 E%
carbohydrates.[8]
3.2. Gene Expression Differences
In total 290 PBMC samples were available from the 0 and 4 h time
points. Because of a too low RNA quality for NanoString anal-
yses, 24 samples were excluded (RNA integrity number < 5.5),
Table 2. Baseline characteristics of the participants.
Mean/n SD
Participants [n] 47
Sex [n, male/female] 14/33
Age [y] 35 12
BMI [kg m−2] 24.1 3.9




HDL-C [mmol L−1] 1.7 0.4
LDL-C [mmol L−1] 3.0 0.8
ApoA1 [g L−1] 1.6 0.2
ApoB [g L−1] 0.9 0.2
Glucose [mmol L−1] 4.9 0.5
Insulin [pmol L−1] 51 32
hsCRP [mg L−1] 1.3 1.4
Systolic BP [mm Hg] 114 11
Diastolic BP [mm Hg] 67 8
ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; BP, blood pressure; hsCRP, high-
sensitivity C-reactive protein; SD, standard deviation.
and 12 samples were excluded after quality control. Hence, gene
expression analyses were performed with 254 samples (butter
n = 60, cheese n = 60, whipped cream n = 70, and sour cream
n = 64, Figure 1). The change in the proportion of lymphocytes
and monocytes in whole blood from 0 to 4 h did not differ be-
tween the four meals (p = 0.95 and p = 0.92, respectively; data
not shown). Of the 609 genes analyzed, 35 genes were differen-
tially altered between the meals (p < 0.05, Table S2, Supporting
Information). These 35 genes were grouped by function, and the
largest gene groups were lymphocyte activation, cytokine signal-
ing, antigen presentation, and chemokine signaling (Figure 2). In
addition, genes related to cell adhesion, complement system, im-
mune signaling, TLR and TNF signaling, lipidmetabolism, host–
virus interactions, and apoptosis were differentially altered be-
tween the meals. Pairwise comparisons between meals revealed
that gene expression changes after intake of cheese and butter
differed most from the other meals (Figure 2; Table S3, Support-
ing Information). Gene expression changes after intake of the
non-fermented products, butter and whipped cream, were only
significantly different from the two fermented dairy products,
cheese and sour cream. Hence, there were no significant differ-
ences between the two non-fermented products after pairwise
comparisons.Moreover, the gene expression changes after intake
of cheese were mostly significantly different from the changes
after intake of the non-fermented products butter and whipped
cream, although there were some significant differences between
cheese and sour cream. Strikingly, expression of many of the
genes related to lymphocyte activation, cytokine signaling, and
chemokine signaling were reduced after intake of cheese and in-
creased after intake of butter. Finally, PBMC expression of anti-
gen presentation related genes increased after intake of cheese
and decreased after intake of butter and whipped cream (Fig-
ure 2).
Within each meal from fasting to 4 h postprandially, the
expression of 35, 22, 25, and 34 genes was altered after intake
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Figure 1. Flow chart of the samples included in the gene expression analyses (right) and the analyses of circulating inflammatorymarkers andmetabolites
(left). NMR, nuclear magnetic resonance, PBMC, peripheral blood mononuclear cell, Sour c., sour cream, whipped c., whipped cream.
of butter, cheese, whipped cream, and sour cream, respectively
(FDR < 10%, Figure 3). Among the gene transcripts that were
altered within each meal, there were overlaps between the meals
(Figure 3). All the genes with a significantly altered expression
within more than one meal were altered in the same direction.
Results of the within meal analyses for all 609 genes are shown
in Table S4, Supporting Information.
3.3. Circulating Inflammatory Markers
In total, 290 serum samples were available for ELISA analyses
from the 0 and 6 h time points (butter n = 72, cheese n = 70,
whipped cream n = 76, and sour cream n = 72, Figure 1). There
were no significant differences between the meals in the change
of circulating ICAM-1, VCAM-1, IL-6, hsCRP, TNF𝛼, TNFR1, or
TNFR2 (Table S5, Supporting Information). However, the change
in serum concentrations of E-selectin from fasting to 6 h post-
prandially was significantly different between the four meals
(p = 0.03, Figure 4). The concentration of E-selectin decreased
after intake of cheese and increased after intake of whipped
cream, although this difference was not significant in the pair-
wise meal comparisons (p = 0.05, Table S6, Supporting Informa-
tion). In the within-meal analyses, the concentration of adhesion
molecules increased after intake of the non-fermented products
(Table S7, Supporting Information); Intake of butter increased
ICAM-1 and VCAM-1 concentrations, while whipped cream in-
creased E-selectin concentrations. The concentration of adhesion
molecules did not change after intake of the fermented dairy
products. Finally, intake of butter and whipped cream reduced
TNF𝛼 concentrations and intake of cheese and whipped cream
reduced TNFR2 concentrations (Table S7, Supporting Informa-
tion).
3.4. Metabolite Changes and Correlations with Gene Expression
Changes
In total 290 plasma sampleswere available forNMRmetabolomic
analyses of metabolites from the 0 and 4 h time points (butter
n = 72, cheese n = 70, whipped cream n = 76, and sour cream
n = 72, Figure 1). The plasma concentrations of alanine, histi-
dine, isoleucine, leucine, valine, phenylalanine, and tyrosine in-
creased from fasting to 4 h postprandially after intake of cheese,
while the concentration of these amino acids decreased after in-
take of the three other dairy products (Figure 5). The overall meal
effect was significant for these amino acids, and pairwise meal
comparisons revealed that the increase after intake of cheese was
significantly different from the reductions after intake of all the
three other meals (Tables S8 and S9, Supporting Information).
The plasma concentration of glutamine increased after of all four
meals, and pairwise comparisons showed that the increase was
greater after intake of cheese than butter and whipped cream
(Figure 5). In addition, the overall meal effect for lactate and 3-
hydroxybutyrate was significant (Table S8, Supporting Informa-
tion). The lactate concentration increased significantly more af-
ter intake of butter compared to cheese, and the concentration
of 3-hydroxybutyrate increased significantly more after intake of
butter and whipped cream compared to cheese and sour cream.
We correlated the change in expression of genes with a
significant overall meal effect with the changes in all metabo-
lites analyzed with NMR spectroscopy (Figure 6; Table S10,
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Figure 2. Genes with a significantly different change (p < 0.05) across the four meals, grouped by function. The gene expression heatmap shows the
estimates of change within each meal; log-ratio adjusted for sex, age, BMI, and visit as fixed effects and subject ID as a random effect. p-values of the
overall meal effect from the mixed model analyses are shown to the right. Significant differences (p < 0.05) in the pairwise meal comparisons, analyzed
with least-squares means, are indicated with letters; B, significantly different compared to butter, C, significantly different compared to cheese, WC,
significantly different compared to whipped cream and SC, significantly different compared to sour cream.
Supporting Information). In general, the changes in expression
of genes related to lymphocyte activation and cytokine signaling
were negatively correlated, while genes related to antigen presen-
tation were positively correlated with the changes in amino acids.
Branched-chain and aromatic amino acids had the strongest
correlations with gene expression changes. Several of the genes
with a reduced expression after intake of cheese compared to
the other meals were negatively correlated with the changes
in amino acid concentrations. Conversely, several of the genes
with an increased expression after intake of cheese were posi-
tively correlated with the changes in amino acid concentrations
(Figures 2 and 6).
4. Discussion
In this study, we have shown that intake of a high-fat meal com-
posed of fermented dairy products, and especially cheese, has a
less pro-inflammatory effect than intake of the non-fermented
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Figure 3. Genes that were altered from fasting to 4 h postprandially within each meal (FDR < 10%). Genes with a reduced expression are shown in red
and genes with an increased expression are shown in black. Log2-transformed counts at 0 and 4 h postprandially within each meal were analyzed with
a paired t-test.
Figure 4. Changes in serum E-selectin concentrations (ng mL−1), adjusted for sex, age, BMI, and visit as fixed effects and subject ID as a random effect,
after intake of meals containing butter, cheese, whipped cream, and sour cream. The overall difference in change between the four meals was tested
with a linear mixed model and the pairwise meal comparisons were analyzed with least square means.
dairy products butter and whipped cream. This was demon-
strated by altered PBMC expression of genes related to lym-
phocyte activation, cytokine and chemokine signaling, as well
as cell adhesion between the four meals we investigated. Pair-
wise comparisons revealed that the changes after intake of the
non-fermented products were only significantly different from
the fermented products. Additionally, only the non-fermented
dairy products increased circulating concentrations of adhesion
molecules.
Intake of high-fat meals rich in SFA may induce a post-
prandial inflammatory response,[30] in agreement with the
results we observed after intake of butter and whipped cream.
In a systematic review of observational studies, intake of SFA
was associated with elevated concentrations of cytokines and
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Figure 5. Changes in plasma concentrations (mmol L−1) of the amino acids alanine, glutamine, histidine, isoleucine, leucine, valine, and phenylalanine
adjusted for sex, age, BMI, and visit as fixed effects and subject ID as a random effect, after intake of meals containing butter, cheese, whipped cream,
and sour cream. The overall difference in change between the four meals was tested with a linear mixed model.
adhesion molecules.[31] In line with this, we found increased
concentrations of ICAM-1, VCAM-1, and E-selectin, and in-
creased expression of cell adhesion related genes after intake of
butter and whipped cream. Although intake of high-fat dairy has
been shown to increase postprandial CRP concentrations,[32] we
did not find that any of the high-fat dairy meals increased CRP.
Several mechanisms may be involved in the pro-inflammatory
response we observed after intake of butter and whipped cream.
High-fat meals may promote an inflammatory response through
LPS-TLR4 binding that activates nuclear factor kappa B and
expression of inflammation-related genes.[33] SFA may also
modify the gut microbiota to overproduce LPS, hence worsening
the inflammatory response of a high-fat meal.[3,34]
The meals containing cheese and sour cream induced a less
pro-inflammatory response than the meals containing butter
and whipped cream, although they contained the same amount
of fat and fatty acid composition. The response after intake of
cheese differed the most from the non-fermented products.
Cheese contains more protein than the three other meals in this
study, and we found that plasma concentrations of amino acids
increased after intake of cheese compared to the other meals.
Similarly, the concentration of glutamine, isoleucine, leucine,
valine, and tyrosine increased more after intake of cheese com-
pared to milk in a study that aimed to find intake biomarkers
for milk and cheese.[16] We found that changes in amino acids,
especially the branched-chain amino acids (BCAA) and tyrosine,
correlated with gene expression, suggesting that the amino acids
are involved in mediating the less pro-inflammatory PBMC gene
expression response observed after intake of cheese. Although
little is known about effects of dairy protein and amino acid
intake on gene expression, it has been found that intake of
dipeptides of tryptophan and tyrosine found in cheese and other
fermented dairy products prevented LPS induced inflammation
in microglial cells in an Alzheimer’s mouse model.[35] Moreover,
an in vitro study showed that physiological concentrations of
BCAA reduced inflammation-related gene expression in hu-
man endothelial cells, and BCAA supplementation improved
immune function in humans and reduced inflammatory gene
expression in liver and adipose tissue of obese mice.[36–38] How-
ever, we have previously reported minor effects on circulating
inflammatory markers after intake of a protein-enriched milk in
older adults,[39] although the same protein-enriched milk altered
PBMC expression of genes related to immune function.[40]
Cheese is also rich in calcium, which has been shown to sup-
press inflammatory stress.[41] This may explain why cheese that
contained seven times more calcium than sour cream induced
a more anti-inflammatory PBMC gene expression response.
The gene expression changes after intake of the non-fermented
products were only significantly different from the fermented
products in pairwise meal comparisons, indicating that there is
an effect of the fermentation. A systematic review of clinical trials
investigating inflammatory markers reported that only studies
of intake of fermented, and not non-fermented, dairy products
demonstrated an anti-inflammatory activity, which is in line
with our findings.[42] It has been shown that compared to milk
(non-fermented), intake of yoghurt (fermented) caused a smaller
increase of blood concentrations of indole metabolites produced
by microbiota. These metabolites can activate the aryl hydrocar-
bon receptor, which is involved in immune regulation.[43] In the
same study, PBMC expression of inflammation-related genes
was more reduced after intake of yoghurt compared to milk.[44]
Intake of whipped cream, a high-fat non-fermented dairy
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Figure 6. Correlation heatmap of genes with a significantly different change between the four dairy meals, and changes in plasma concentrations of
metabolites analyzed with Spearman’s correlation. Genes are grouped by function and metabolites are grouped by type. Significant correlations are
indicated with symbols: ***p < 0.001, **p < 0.01, *p < 0.05.
product, has been shown to increase concentrations of cir-
culating inflammatory markers.[45] Furthermore, intake of
high-fat fermented dairy products, including cheese, for two
weeks reduced IL-6 concentrations compared to the high-fat
non-fermented products butter and ice cream.[46] These findings
concur with our results and suggest that fermented dairy prod-
ucts induce a less inflammatory response than non-fermented
dairy products. Although the underlying mechanisms of the
anti-inflammatory effect of fermented dairy products is poorly
understood, fermentation products of lactic acid bacteria may
Mol. Nutr. Food Res. 2020, 64, 2000319 © 2020 The Authors. Published by Wiley-VCH GmbH2000319 (9 of 11)
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modulate immune responses.[47,48] Furthermore, intake of
fermented dairy products alter the composition of the gut micro-
biota, which has been hypothesized tomediate their beneficial ef-
fects on inflammation.[49,50] Finally, the dairy matrix may modify
the interactions between nutrients and may therefor explain dif-
ferences in health effects of intake of different dairy products.[15]
Unexpectedly, PBMC expression of genes related to antigen
presentation increased after intake of cheese, while it decreased
following intake of butter and whipped cream. In line with this,
PBMCexpression of antigen presentation genes in rats decreased
after a 4-week high-fat diet, and increased after a high-protein
diet.[51] Hence, the three times higher content of protein in the
meal containing cheese compared to the other meals in the cur-
rent study may explain the differential effects on PBMC expres-
sion of antigen presentation related genes.
In addition to investigating effects on genes related to in-
flammation, we analyzed expression of 30 genes related to lipid
metabolism. We found that postprandial expression of ABCA1
and ABCG1 increased within all four meals, which is in line
with studies investigating intake of SFA compared to MUFA and
PUFA.[52–54] Upregulation of these genes may indicate that there
is an increased cholesterol efflux and reverse cholesterol trans-
port via HDL, however, in this study, HDL-C increased postpran-
dially only after intake of sour cream.[8] Furthermore, we found
that SREBF1 expression increased after intake of butter, sour
cream, andwhipped cream. Thismay lead to an increased expres-
sion of fatty acids synthesis genes and increased de novo lipoge-
nesis that may have contributed to the postprandial TG increase
in this study, as we previously reported.[8] On the other hand,
expression of SREBF2 decreased after intake of all four meals,
but only significantly after intake of whipped cream and sour
cream. Other studies have also found that expression of SREBF1
increases and SREBF2 decreases after intake of SFA compared
to PUFA and MUFA.[52,53] A reduced SREBF2 expression could
lead to a lower expression of its target gene LDLR, encoding the
LDL receptor. In this study,mRNA expression of LDLR decreased
after intake of all four meals, however, only significantly after
intake of butter. Correspondingly, it has been shown that intake
of SFA reduces PBMC expression of LDLR compared to PUFA
andMUFA, which has been suggested as a potential mechanism
for the LDL-C increasing effect of SFA in the long term.[53–55]
This study is strengthened by the randomized cross-over de-
sign with meals composed of four different dairy products, but
with the same content of fat and SFA. Because we aimed to test
the effect of intake of whole products, and not specific nutrients,
we cannot dissect whether the fermentation status, the protein or
calcium content or other factors causes the observed effects. Fur-
thermore, as we measured the postprandial response to intake
of different high-fat dairy products, we cannot draw conclusions
about health effects of long-term consumption. InWestern coun-
tries today, most people are in the postprandial phase during the
entire day and postprandial responses may therefore be key to
understanding long-term effects. The lack of significant findings
on the majority of circulating inflammatory markers may be due
to the relatively small sample size, or that changes occur after the
last blood sampling 6 h postprandially. In line with our findings,
a postprandial study that compared intake of milk, butter, cream,
yoghurt, and cheese found no differences in inflammatory
biomarkers.[18] Moreover, we only measured PBMC gene expres-
sion at fasting and 4 h postprandially; nonetheless, according
to a study by Sagaya et al., the change from fasting to 4 h may
capture the main postprandial response.[56] This study is also
limited by the lack of analyses of the PBMC transcripts’ protein
products. However, other postprandial studies of dairy products
have found effects on gene expression, and not protein levels,
indicating that it may be appropriate to study gene expression
in postprandial studies of dairy intake.[44,50] Finally, as the mixed
model analyses are not adjusted for multiple testing, the results
needs to be interpreted with some caution.
To conclude, we have shown that intake of fermented dairy
products, and especially cheese, induces a less inflamma-
tory postprandial PBMC gene expression response than non-
fermented dairy products. The high protein and calcium content
of the cheese may explain some of these differences. Our find-
ings may partly explain why studies on health effects of intake of
dairy products are inconsistent, and highlight the need to cate-
gorize dairy products into specific food groups. We also showed
that all the high-fat meals rich in SFA altered PBMC expression
of lipid metabolism related genes in the same direction, which
may contribute to an understanding of SFA’s adverse effects on
blood lipids.
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